These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35460095)

  • 1. Review article: rethinking the "ladder" approach to reflux-like symptom management in the era of PPI "resistance" - a multidisciplinary perspective.
    Hungin APS; Scarpignato C; Keefer L; Corsetti M; Anastasiou F; Muris JWM; Mendive JM; Kahrilas PJ
    Aliment Pharmacol Ther; 2022 Jun; 55(12):1492-1500. PubMed ID: 35460095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
    Azzam RS
    Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with refractory reflux symptoms: What do they have and how should they be managed?
    Kahrilas PJ; Keefer L; Pandolfino JE
    Neurogastroenterol Motil; 2015 Sep; 27(9):1195-201. PubMed ID: 26303047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
    Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
    Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: the PASS (Proton pump inhibitor Acid Suppression Symptom) test.
    Armstrong D; Veldhuyzen SJ; Chung SA; Shapiro CM; Dhillon S; Escobedo S; Chakraborty BK; Mann V; Tanser L; Nevin K
    Can J Gastroenterol; 2005 Jun; 19(6):350-8. PubMed ID: 15997268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial.
    Watson G; O'Hara J; Carding P; Lecouturier J; Stocken D; Fouweather T; Wilson J
    Trials; 2016 Apr; 17():175. PubMed ID: 27036555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment.
    Spechler SJ
    Gastroenterol Clin North Am; 2020 Sep; 49(3):437-450. PubMed ID: 32718563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.
    Toghanian S; Johnson DA; Stålhammar NO; Zerbib F
    Clin Drug Investig; 2011 Oct; 31(10):703-15. PubMed ID: 21756007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
    Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
    World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
    Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
    Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal management of severe symptomatic gastroesophageal reflux disease.
    Talley NJ; Zand Irani M
    J Intern Med; 2021 Feb; 289(2):162-178. PubMed ID: 32691466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
    Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
    Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GERD for the nongastroenterologist: successful evaluation, management, and lifestyle-based symptom control.
    Stein E; Sloan J; Sonu I; Kathpalia P; Jodorkovsky D
    Ann N Y Acad Sci; 2020 Dec; 1482(1):106-112. PubMed ID: 32944973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.
    Becher A; El-Serag H
    Aliment Pharmacol Ther; 2011 Sep; 34(6):618-27. PubMed ID: 21770991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Proton Pump Inhibitor Nonresponder: a Behavioral Approach to Improvement and Wellness.
    Riehl ME; Chen JW
    Curr Gastroenterol Rep; 2018 Jun; 20(7):34. PubMed ID: 29886565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent gastro-oesophageal reflux symptoms despite proton pump inhibitor therapy.
    Ang D; How CH; Ang TL
    Singapore Med J; 2016 Oct; 57(10):546-551. PubMed ID: 27779277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.